Investor FAQ

Investors

General | Corporate Governance | Corporate Information

General

Echo became a public company on September 14, 2007 as a result of the merger of Sontra Medical Corporation (OTC BB: SONT) and then privately held Echo Therapeutics, Inc. (ETI). Following the merger, Sontra changed its name to Echo Therapeutics, Inc. on October 8, 2007 and began trading on the OTC BB under the stock symbol ECTE. On June 29, 2011, Echo began trading on the NASDAQ Capital Market.

2. On what exchange does Echo trade and what is its ticker symbol?

Echo is traded on the NASDAQ Capital Market under the stock symbol "ECTE".

3. How many shares of Echo are outstanding?

As of August 10, 2011, Echo has 34,248,796 basic and diluted weighted average common shares outstanding.

4. How can I invest in Echo? Can I purchase Echo stock directly from the company?

The company does not have a direct stock purchase plan. Shares of Echo common stock may be bought through a broker or stock purchase service of your choice.

5. When do I receive my certificate of ownership?

Please contact Echo’s transfer agent with questions about your stock certificates.

6. Who is your transfer agent and how do I contact them?

Wells Fargo Shareowner Services
161 North Concord Exchange
South St. Paul, MN 55075
Telephone: (800)-689-8788

7. What is Echo's policy on dividends?

To date, Echo has not paid cash dividends. The company expects to retain future earnings to fund the development and growth of the business and does not anticipate declaring or paying cash dividends in the foreseeable future.

8. Does Echo have convertible debt?

No, Echo does not have any convertible debt.

9. Who are Echo's independent auditors?

Wolf & Company, P.C., an independent registered public accounting firm
99 High Street
Boston, MA 02110-2335
Telephone: (617) 439-9700
www.wolfandco.com

10. When does Echo report financial results?

Third quarter ending September 30, 2011, results will be reported by November 14, 2011
Fourth quarter and full year ending December 31, 2011, results will be reported by March 30, 2012

11. When and where is the Echo Annual Stockholders' Meeting?

Was last held on July 13, 2011 at:
8 Penn Center

1628 JFK Blvd.
Philadelphia, Pennsylvania 19103

12. How do I contact Investor Relations?

You may contact Christine Olimpio, Telephone: (215) 717-4104 or email:

Corporate Governance Information

1. Where can I get information on Echo's Corporate Governance practices?

Please visit the following section of our website to read our corporate governance guidelines. For additional questions regarding corporate governance at Echo, please contact: . Please use this e-mail for legitimate business inquiries. Solicitations of any kind will be ignored.

2. How can I contact Echo's Board of Directors?

You may contact our Board of Directors via email through Echo’s website. Please visit: . Please use this e-mail to contact the Board of Directors for legitimate business inquiries. Solicitations of any kind will be ignored.

3. How many members of Echo's board of directors are independent under SEC standards?

The Board of Directors has determined that each of Messrs. Vincent D. Enright, William F. Grieco, and James F. Smith, constituting three of the four directors of the Company, satisfies the criteria for being an "independent director" under the standards of the Nasdaq Stock Market, Inc. ("Nasdaq") and has no material relationship with the Company other than by virtue of service on the Board of Directors.